{"result": "(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a medical condition characterized by consistently elevated blood pressure, which can lead to serious health complications if untreated.)\n##\n(\"entity\"<|>HYPERKALEMIA<|>EVENT<|>Hyperkalemia is a condition where there is an elevated level of potassium in the blood, which can cause serious cardiac issues.)\n##\n(\"entity\"<|>HYPONATREMIA<|>EVENT<|>Hyponatremia is a condition characterized by low sodium levels in the blood, which can lead to neurological complications.)\n##\n(\"entity\"<|>ALDOSTERONE SUPPLEMENTATION<|>EVENT<|>Aldosterone supplementation is a treatment approach for conditions like adrenal insufficiency, where the body does not produce enough aldosterone.)\n##\n(\"relationship\"<|>HIPERTENSION<|>HIPERALDOSTERONISMO PRIMARIO<|>Hiperaldosteronismo primario es una de las causas más frecuentes de hipertensión secundaria.<|>9)\n##\n(\"relationship\"<|>HYPERKALEMIA<|>HIPERALDOSTERONISMO PRIMARIO<|>La hiperkalemia puede ser un síntoma asociado en algunos casos de hiperaldosteronismo primario, aunque típicamente se presenta hipopotasemia.<|>5)\n##\n(\"relationship\"<|>HYPONATREMIA<|>HIPERALDOSTERONISMO PRIMARIO<|>La hiponatremia puede ocurrir en el contexto de resistencia a la acción de los mineralocorticoides en el hiperaldosteronismo.<|>5)\n##\n(\"relationship\"<|>ALDOSTERONE SUPPLEMENTATION<|>HIPERALDOSTERONISMO PRIMARIO<|>La suplementación con aldosterona no es indicada en pacientes con hiperaldosteronismo primario, ya que la condición se caracteriza por niveles elevados de esta hormona.<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: orno con comportamiento autosómi-                             res con herencia autosómica dominante asociadas a las mutaciones en este gen.\n     co dominante, pero en el que no existe supresión de la aldosterona con dexametasona ni                             El seudohipoaldosteronismo generalizado de tipo 1 es una forma más grave de resisten-\n     un resultado positivo en el estudio genético. Los pacientes son indistinguibles del resto de                       cia a los mineralocorticoides con afectación pierde sal a nivel del riñón, colon, glándulas\n     pacientes con hiperaldosteronismo primario y pueden presentar una enfermedad unilateral                            sudoríparas y salivales. El cuadro clínico neonatal inicial se puede complicar con arritmias\n                                                                                                                        y shock. El incremento de volumen de líquido en la vía área puede producir manifestaciones\n\n\n\n270                                                                                                                                                                                                                                                 271\n---\n                                                                                                                                                                                                                          SUPRARRENALES                                        5\n\n\n\n         clínicas que recuerdan a la fibrosis quística. La enfermedad tiene una herencia autosómica                                              6.  HTA e historia familiar de HTA o enfermedad cerebrovascular en menores de 40 años.\n         recesiva y está causada por mutaciones en los genes que codifican para las subunida-                                                    7. En todos los pacientes con hipertensión que tienen familiares diagnosticados\n         des del canal de sodio sensible a amilorida (ENaC): SCNN1A, SCNN1B y SCNN1G.                                                                de hiperaldosteronismo primario.\n         Referencias:                                                                                                                            Referencias:\n         • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of      • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison\n           Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.                                                                       Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n                                                                                                                                                 • Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection,\n                                                                                                                                                   diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889-916.\n                                                                                                                                                 • Lahera Vargas M. Hiperaldosteronismo primario. Manual de Endocrinología y Nutrición. Disponible en: https://manual.seen.es\n         Se debe sospechar un hiperaldosteronismo ante los siguientes cuadros clínicos                                                             (última modificación: 25 de noviembre de 2015).\n     17                                                                                                                                          • Young WF, Jr. Diagnosis of primary aldosteronism. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. Literature\n         excepto:                                                                                                                                  review current through: Apr. 2019.\n                                                                                                                                                 • Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n         A. HTA e hiperpotasemia.                                                                                                                  of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.\n         B. HTA e incidentaloma suprarrenal.\n         C. HTA grave.                                                                                                                       18  ¿En cuál de las siguientes patologías está indicada la suplementación con potasio?\n         D.  HTA resistente al tratamiento (PAS/PAD >140/90 mmHg a pesar de 3 fármacos).                                                         A. Seudohipoaldosteronismo.\n                                                                                                                                                 B. Insuficiencia suprarrenal secundaria.\n         COMENTARIO                                                                                                                              C. Hipoaldosteronismo hiporreninémico.\n         Actualmente no se recomienda realizar un cribado universal de hiperaldosteronismo pri-                                                  D.  Ninguna de las anteriores.\n         mario en todos los pacientes con hipertensión arterial (HTA), a pesar de ser la causa más\n         frecuente de HTA secundaria y de que su mortalidad y morbilidad son significativamente\n         mayores que la de sujetos pareados por edad, sexo y nivel de presión arterial cuando la                                                 COMENTARIO\n         causa es una hipertensión esencial.                                                                                                     El seudohipoaldosteronismo se define por la presencia de resistencia a la acción de los mi-\n         Un rasgo clínico clásico del hiperaldosteronismo primario es la hipopotasemia; sin em-                                                  neralocorticoides que provoca un cuadro clínico de síndrome pierde sal con hiponatremia e\n         bargo, solo del 9% al 37% de los                pacientes con hiperaldosteronismo primario presentan                                    hiperpotasemia, pero en el que aparecen niveles elevados de aldosterona y renina.\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HIPERALDOSTERONISMO PRIMARIO<|>EVENT<|>Hiperaldosteronismo primario es una condición médica que causa hipertensión arterial y puede llevar a complicaciones graves como arritmias y shock.)\n##\n(\"entity\"<|>SEUDOHIPOALDOSTERONISMO<|>EVENT<|>El seudohipoaldosteronismo es una condición caracterizada por resistencia a los mineralocorticoides, provocando un síndrome de pérdida de sal.)\n##\n(\"entity\"<|>SCNN1A<|>GENE<|>SCNN1A es un gen que codifica para una subunidad del canal de sodio sensible a amilorida, implicado en el hiperaldosteronismo primario.)\n##\n(\"entity\"<|>SCNN1B<|>GENE<|>SCNN1B es un gen que codifica para una subunidad del canal de sodio sensible a amilorida, implicado en el hiperaldosteronismo primario.)\n##\n(\"entity\"<|>SCNN1G<|>GENE<|>SCNN1G es un gen que codifica para una subunidad del canal de sodio sensible a amilorida, implicado en el hiperaldosteronismo primario.)\n##\n(\"entity\"<|>ALDOSTERONA<|>HORMONE<|>La aldosterona es una hormona que regula el equilibrio de sodio y potasio en el cuerpo, y sus niveles son elevados en el hiperaldosteronismo primario.)\n##\n(\"entity\"<|>RENINA<|>HORMONE<|>La renina es una enzima que juega un papel crucial en la regulación de la presión arterial y los niveles de electrolitos, y sus niveles son elevados en el hiperaldosteronismo primario.)\n##\n(\"relationship\"<|>HIPERALDOSTERONISMO PRIMARIO<|>SEUDOHIPOALDOSTERONISMO<|>Ambas condiciones están relacionadas con la regulación de la aldosterona y pueden presentar síntomas similares, pero tienen diferentes mecanismos patológicos.<|>4)\n##\n(\"relationship\"<|>SCNN1A<|>HIPERALDOSTERONISMO PRIMARIO<|>Mutaciones en el gen SCNN1A están asociadas con el desarrollo de hiperaldosteronismo primario.<|>7)\n##\n(\"relationship\"<|>SCNN1B<|>HIPERALDOSTERONISMO PRIMARIO<|>Mutaciones en el gen SCNN1B están asociadas con el desarrollo de hiperaldosteronismo primario.<|>7)\n##\n(\"relationship\"<|>SCNN1G<|>HIPERALDOSTERONISMO PRIMARIO<|>Mutaciones en el gen SCNN1G están asociadas con el desarrollo de hiperaldosteronismo primario.<|>7)\n##\n(\"relationship\"<|>ALDOSTERONA<|>HIPERALDOSTERONISMO PRIMARIO<|>Los niveles de aldosterona son elevados en pacientes con hiperaldosteronismo primario, lo que contribuye a la hipertensión.<|>8)\n##\n(\"relationship\"<|>RENINA<|>HIPERALDOSTERONISMO PRIMARIO<|>Los niveles de renina son elevados en pacientes con hiperaldosteronismo primario, lo que indica una respuesta del sistema renina-angiotensina.<|>8)\n<|COMPLETE|>"}]}